BioSpace News Archive

West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, today announced that it is in the best interests of shareholders to hold a virtual shareholder meeting due to the ongoing COVID-19 pandemic and restrictions issued by the Commonwealth of Pennsylvania and the Center for Disease Control.

Aurinia Pharmaceuticals Inc. announced the appointment of Timothy P. Walbert, chairman, president and chief executive officer of Horizon Therapeutics plc, to the Company’s Board of Directors.

DaVita Kidney Care protects patients, physicians and teammates amid the COVID-19 pandemic by requiring them to wear masks in its U.S. dialysis centers..

Myriad Genetics, Inc., a global leader in molecular diagnostics and precision medicine, announced the publication of a meta-analysis of four clinical trials demonstrating that the GeneSight® Psychotropic test significantly improves clinical outcomes among patients with major depressive disorder.

Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for mobile handset and wireless devices, announced it will host a conference call with Stifel Financial on Monday, April 20, 2020. Stifel Financial Virtual Fireside with Resonant (RESN) Management Monday, April 20, 2020 at 1:00 pm ET Featuring Chairman & CEO George B. Holmes, COO Dylan Kelly, and Adviso

Genesis HealthCare, one of the largest post-acute care providers in the United States, announced that its founder, Michael R. Walker passed away over the weekend after a long-term illness and complications from COVID-19.

Spectral Medical Inc. announced that Health Canada has issued an Interim Order expanding the already approved indications for use of Spectral’s Toraymyxin™ hemoperfusion cartridge specifically for patients with COVID-19.

FibroGen, Inc. announced that the United Kingdom’s High Court of Justice has held certain patents1 relating to methods of using hypoxia-inducible factor prolyl hydroxylase inhibitors to be invalid.

Centene Corporation announced that its subsidiary Centurion has been awarded a contract by the Kansas Department of Administration to provide healthcare services in the Department of Corrections’ facilities.

CytoSorbents Corporation announced that the U.S. Food and Drug Administration has granted Breakthrough Designation to CytoSorb for the removal of ticagrelor in a cardiopulmonary bypass circuit during emergent and urgent cardiothoracic surgery.